Identification of angiotensin-converting enzyme 2 (ACE2) protein as the potential biomarker in SARS-CoV-2 infection-related lung cancer using computational analysis.

This study uncovers the relationship between COVID-19 disease and lung cancer. We identified ACE2 and also its co-expressed proteins are the potential biomarker and therapy as the current COVID-19 disease and lung cancer. PMID: 32916258 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32916258?dopt=Abstract

Source: Genomics - September 7, 2020 Category: Genetics & Stem Cells Authors: Samad A, Jafar T, Rafi JH Tags: Genomics Source Type: research